• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

墨西哥利什曼原虫稳定的两性霉素抗性无鞭毛体和前鞭毛体的产生及特性研究

Production and characterization of stable amphotericin-resistant amastigotes and promastigotes of Leishmania mexicana.

作者信息

Al-Mohammed Hamdan I, Chance Michael L, Bates Paul A

机构信息

Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, United Kingdom.

出版信息

Antimicrob Agents Chemother. 2005 Aug;49(8):3274-80. doi: 10.1128/AAC.49.8.3274-3280.2005.

DOI:10.1128/AAC.49.8.3274-3280.2005
PMID:16048936
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1196255/
Abstract

The sensitivities of Leishmania mexicana amastigote and promastigote forms to amphotericin B were investigated in vitro and found to be strongly influenced by the culture media used. When differences in culture media were minimized, there was no significant difference in the 50% inhibitory concentration values between the two life cycle stages. Stable amphotericin B-resistant amastigote and promastigote lines were produced by the application of increasing drug pressure to long-term cultures. Lines capable of growth in concentrations of amphotericin B lethal to normal parasites were produced. Compared to normal parasites, these amphotericin-resistant lines showed marked differences in membrane sterol compositions, with very high levels of 4,14,dimethyl-cholesta-8,24-dienol and other methyl sterols. They also showed a consistent morphological feature, the presence of multilamellar membrane-like material in the flagellar pocket, revealed by transmission electron microscopy. Amphotericin-resistant parasites were capable of infecting BALB/c mice, but the resulting lesion growth was slower than that after infection with normal parasites. However, unlike normal parasites, the amphotericin-resistant parasites were unaffected by experimental chemotherapy with amphotericin B. These results show that amphotericin B resistance could arise as a result of increased clinical use of amphotericin B therapy.

摘要

对墨西哥利什曼原虫无鞭毛体和前鞭毛体形式对两性霉素B的敏感性进行了体外研究,发现其受所用培养基的强烈影响。当培养基差异减至最小时,两个生命周期阶段之间的50%抑制浓度值没有显著差异。通过对长期培养物施加递增的药物压力,产生了稳定的两性霉素B抗性无鞭毛体和前鞭毛体株系。获得了能够在对正常寄生虫致死浓度的两性霉素B中生长的株系。与正常寄生虫相比,这些抗两性霉素株系在膜甾醇组成上表现出明显差异,含有非常高水平的4,14-二甲基胆甾-8,24-二烯醇和其他甲基甾醇。它们还表现出一致的形态学特征,即通过透射电子显微镜观察到鞭毛囊中存在多层膜样物质。抗两性霉素的寄生虫能够感染BALB/c小鼠,但产生的病变生长比感染正常寄生虫后慢。然而,与正常寄生虫不同,抗两性霉素的寄生虫不受两性霉素B实验性化疗的影响。这些结果表明,两性霉素B抗性可能是由于两性霉素B治疗临床使用增加而产生的。

相似文献

1
Production and characterization of stable amphotericin-resistant amastigotes and promastigotes of Leishmania mexicana.墨西哥利什曼原虫稳定的两性霉素抗性无鞭毛体和前鞭毛体的产生及特性研究
Antimicrob Agents Chemother. 2005 Aug;49(8):3274-80. doi: 10.1128/AAC.49.8.3274-3280.2005.
2
Poloxamer 407 (Pluronic(®) F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis.基于泊洛沙姆407(普朗尼克(®)F127)的两性霉素B聚合物胶束:体外生物活性、毒性及对小鼠皮肤利什曼病的体内治疗效果
Exp Parasitol. 2016 Oct;169:34-42. doi: 10.1016/j.exppara.2016.07.005. Epub 2016 Jul 15.
3
In vitro sensitivity of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Brazilian isolates to meglumine antimoniate and amphotericin B.巴西利什曼原虫(Viannia)和巴西利什曼原虫(Leishmania)巴西分离株对葡甲胺锑和两性霉素 B 的体外敏感性。
Trop Med Int Health. 2010 Jan;15(1):68-76. doi: 10.1111/j.1365-3156.2009.02414.x. Epub 2009 Oct 26.
4
Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.对一种氯喹啉衍生物针对能够引起皮肤利什曼病和内脏利什曼病的利什曼原虫物种的体外和体内抗利什曼活性进行评估。
Exp Parasitol. 2019 Apr;199:30-37. doi: 10.1016/j.exppara.2019.02.019. Epub 2019 Feb 25.
5
Amphotericin B resistance in Leishmania amazonensis: In vitro and in vivo characterization of a Brazilian clinical isolate.巴西利什曼原虫两性霉素 B 耐药性:巴西临床分离株的体外和体内特征。
PLoS Negl Trop Dis. 2024 May 20;18(5):e0012175. doi: 10.1371/journal.pntd.0012175. eCollection 2024 May.
6
Leishmania donovani: an in vitro study of antimony-resistant amphotericin B-sensitive isolates.杜氏利什曼原虫:锑耐药两性霉素B敏感分离株的体外研究
Exp Parasitol. 2006 Dec;114(4):247-52. doi: 10.1016/j.exppara.2006.03.016. Epub 2006 May 23.
7
The surface membrane of Leishmania mexicana mexicana: comparison of amastigote and promastigote using freeze-fracture cytochemistry.墨西哥利什曼原虫的表面膜:运用冷冻断裂细胞化学对无鞭毛体和前鞭毛体进行比较
Z Parasitenkd. 1986;72(3):281-92. doi: 10.1007/BF00928737.
8
Bovine serum albumin nanoparticles containing amphotericin B were effective in treating murine cutaneous leishmaniasis and reduced the drug toxicity.含有两性霉素B的牛血清白蛋白纳米颗粒在治疗小鼠皮肤利什曼病方面有效,并降低了药物毒性。
Exp Parasitol. 2018 Sep;192:12-18. doi: 10.1016/j.exppara.2018.07.003. Epub 2018 Jul 17.
9
Amphotericin B inhibits entry of Leishmania donovani into primary macrophages.两性霉素 B 抑制杜氏利什曼原虫进入原代巨噬细胞。
Biochem Biophys Res Commun. 2010 Aug 27;399(3):429-33. doi: 10.1016/j.bbrc.2010.07.099. Epub 2010 Aug 3.
10
Efficacy of a Binuclear Cyclopalladated Compound Therapy for Cutaneous Leishmaniasis in the Murine Model of Infection with Leishmania amazonensis and Its Inhibitory Effect on Topoisomerase 1B.双核环钯化合物疗法对亚马逊利什曼原虫感染小鼠模型皮肤利什曼病的疗效及其对拓扑异构酶1B的抑制作用。
Antimicrob Agents Chemother. 2017 Jul 25;61(8). doi: 10.1128/AAC.00688-17. Print 2017 Aug.

引用本文的文献

1
Amphotericin B resistance correlates with increased fitness and in () .两性霉素B耐药性与()中适应性增加相关。 (括号部分原文缺失具体内容无法准确翻译完整)
Front Microbiol. 2023 Apr 6;14:1156061. doi: 10.3389/fmicb.2023.1156061. eCollection 2023.
2
Amphotericin B resistance in Leishmania mexicana: Alterations to sterol metabolism and oxidative stress response.墨西哥利什曼原虫的两性霉素 B 耐药性:固醇代谢和氧化应激反应的改变。
PLoS Negl Trop Dis. 2022 Sep 28;16(9):e0010779. doi: 10.1371/journal.pntd.0010779. eCollection 2022 Sep.
3
Impact of Genetic Diversity and Genome Plasticity of spp. in Treatment and the Search for Novel Chemotherapeutic Targets. spp. 的遗传多样性和基因组可塑性对治疗的影响及新型化疗靶点的寻找。
Front Cell Infect Microbiol. 2022 Jan 24;12:826287. doi: 10.3389/fcimb.2022.826287. eCollection 2022.
4
LmjF.22.0810 from Modulates the Th2-Type Immune Response and Is Involved in Leishmaniasis Outcome.来自利什曼原虫的LmjF.22.0810调节Th2型免疫反应并参与利什曼病的转归。
Biomedicines. 2020 Oct 26;8(11):452. doi: 10.3390/biomedicines8110452.
5
Untargeted metabolomics to understand the basis of phenotypic differences in amphotericin B-resistant parasites.非靶向代谢组学用于了解两性霉素B耐药寄生虫表型差异的基础。
Wellcome Open Res. 2019 Nov 13;4:176. doi: 10.12688/wellcomeopenres.15452.1. eCollection 2019.
6
Antileishmanial Activity and Synergistic Effects of Amphotericin B Deoxycholate with Allicin and Andrographolide against In Vitro.两性霉素B脱氧胆酸盐与大蒜素及穿心莲内酯的抗利什曼原虫活性及其体外协同作用
Pathogens. 2020 Jan 9;9(1):49. doi: 10.3390/pathogens9010049.
7
Effectiveness and Safety of Amphotericin B Deoxycholate, Amphotericin B Colloidal Dispersion, and Liposomal Amphotericin B as Third-Line Treatments for Cutaneous and Mucocutaneous Leishmaniasis: A Retrospective Study.多烯类两性霉素 B 脱氧胆酸盐、两性霉素 B 胶体分散体和脂质体两性霉素 B 作为皮肤和黏膜利什曼病三线治疗的有效性和安全性:一项回顾性研究。
Am J Trop Med Hyg. 2020 Feb;102(2):274-279. doi: 10.4269/ajtmh.18-0514.
8
Comparison of Efficacy of Two Different Concentrations of Intralesional Amphotericin B in the Treatment of Cutaneous Leishmaniasis; A Randomized Controlled Trial.两种不同浓度的两性霉素B皮损内注射治疗皮肤利什曼病的疗效比较:一项随机对照试验
Indian Dermatol Online J. 2019 Nov 1;10(6):627-631. doi: 10.4103/idoj.IDOJ_470_18. eCollection 2019 Nov-Dec.
9
Genomic instability at the locus of sterol C24-methyltransferase promotes amphotericin B resistance in Leishmania parasites.甾醇 C24-甲基转移酶基因座的基因组不稳定性促进了利什曼原虫对抗真菌药物两性霉素 B 的耐药性。
PLoS Negl Trop Dis. 2019 Feb 4;13(2):e0007052. doi: 10.1371/journal.pntd.0007052. eCollection 2019 Feb.
10
Intraspecies differences in natural susceptibility to amphotericine B of clinical isolates of Leishmania subgenus Viannia.利什曼亚属种属内临床分离株对两性霉素 B 天然敏感性的种间差异。
PLoS One. 2018 Apr 26;13(4):e0196247. doi: 10.1371/journal.pone.0196247. eCollection 2018.

本文引用的文献

1
Epidemiological, clinical & pharmacological study of antimony-resistant visceral leishmaniasis in Bihar, India.印度比哈尔邦抗锑性内脏利什曼病的流行病学、临床及药理学研究
Indian J Med Res. 2004 Sep;120(3):166-72.
2
Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheres.用两性霉素B稳定白蛋白微球治疗实验性内脏利什曼病。
Antimicrob Agents Chemother. 2004 Sep;48(9):3246-52. doi: 10.1128/AAC.48.9.3246-3252.2004.
3
Cloning of S-adenosyl-L-methionine:C-24-Delta-sterol-methyltransferase (ERG6) from Leishmania donovani and characterization of mRNAs in wild-type and amphotericin B-Resistant promastigotes.来自杜氏利什曼原虫的S-腺苷-L-甲硫氨酸:C-24-δ-甾醇甲基转移酶(ERG6)的克隆以及野生型和两性霉素B抗性前鞭毛体中mRNA的特性研究
Antimicrob Agents Chemother. 2004 Jul;48(7):2409-14. doi: 10.1128/AAC.48.7.2409-2414.2004.
4
Conjugation of amino-containing drugs to polysaccharides by tosylation: amphotericin B-arabinogalactan conjugates.通过甲苯磺酰化将含氨基药物与多糖结合:两性霉素B-阿拉伯半乳聚糖缀合物
Biomaterials. 2004 Jul;25(15):3049-57. doi: 10.1016/j.biomaterials.2003.09.080.
5
Toxicity and antileishmanial activity of a new stable lipid suspension of amphotericin B.两性霉素B新型稳定脂质混悬液的毒性及抗利什曼原虫活性
Antimicrob Agents Chemother. 2003 Dec;47(12):3774-9. doi: 10.1128/AAC.47.12.3774-3779.2003.
6
In vitro antileishmanial activity of amphotericin B loaded in poly(epsilon-caprolactone) nanospheres.负载于聚(ε-己内酯)纳米球中的两性霉素B的体外抗利什曼原虫活性
J Drug Target. 2002 Dec;10(8):593-9. doi: 10.1080/1061186021000060738.
7
Heated amphotericin to treat leishmaniasis.用加热的两性霉素治疗利什曼病。
Lancet Infect Dis. 2003 Apr;3(4):188. doi: 10.1016/s1473-3099(03)00573-5.
8
Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompetent patients.脂质体两性霉素B治疗免疫功能正常患者的内脏利什曼病
Fundam Clin Pharmacol. 2003 Apr;17(2):183-8. doi: 10.1046/j.1472-8206.2003.00168.x.
9
Leishmaniasis: new approaches to disease control.利什曼病:疾病控制的新方法
BMJ. 2003 Feb 15;326(7385):377-82. doi: 10.1136/bmj.326.7385.377.
10
Oral miltefosine for Indian visceral leishmaniasis.口服米替福新治疗印度内脏利什曼病。
N Engl J Med. 2002 Nov 28;347(22):1739-46. doi: 10.1056/NEJMoa021556.